GlassScriptPhysician profile
Heidi A Tate
NPI 1245568864
$3,362.43
in general payments reported to CMS, 2019-2025
20 companies · $56.09 in 2025
The $56.09 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $941 · 2022: $395 · 2023: $1,348 · 2024: $622 · 2025: $56.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,767.30 |
| Education | $258.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $635.57 | 2021-2023 | Otezla |
| Abbvie INC. | $594.70 | 2021-2025 | |
| Janssen Biotech, INC. | $565.02 | 2021-2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $306.22 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $197.80 | 2021-2023 | Taltz, Olumiant |
| Ucb, INC. | $186.52 | 2021-2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $176.18 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $151.63 | 2021-2024 | Dupixent |
| Incyte Corporation | $107.79 | 2022-2024 | Opzelura |
| Arcutis Biotherapeutics, INC. | $101.79 | 2023-2024 | Zoryve |
| Novartis Pharmaceuticals Corporation | $80.87 | 2022-2025 | |
| Biofrontera INC. | $76.89 | 2021-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Pfizer INC. | $44.77 | 2021-2022 | |
| Leo Pharma INC. | $44.75 | 2022-2023 | Adbry |
| Stemline Therapeutics INC. | $19.08 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $16.61 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $15.07 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.90 | 2022 | |
| Dermavant Sciences, INC. | $13.34 | 2023 | Vtama |
| Genzyme Corporation | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.